stockportfolio.pro
Stocks / BIIB vs RVMD
BIIB vs RVMD
Biogen Inc. and Revolution Medicines, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Biogen Inc. (BIIB) | Revolution Medicines, Inc. (RVMD) | |
|---|---|---|
| Market cap | $29.3B | $31.3B |
| Revenue (latest FY) | $9.89B | $0 |
| Net income (latest FY) | $1.29B | $-1.13B |
| Revenue growth (5y CAGR) | -6.0% | — |
| Net margin | 13.1% | — |
| Return on equity | 7.1% | -69.3% |
| P/E ratio | 21.4 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BIIB — free Open RVMD — freeFrequently asked questions
Which is bigger, BIIB or RVMD?
Revolution Medicines, Inc. is larger by market capitalization — $31.3B versus $29.3B.
Which grows faster, BIIB or RVMD?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.